La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Avanos Medical Performance dei guadagni passati
Il passato criteri di controllo 1/6
Avanos Medical has been growing earnings at an average annual rate of 39.3%, while the Medical Equipment industry saw earnings growing at 11.2% annually. Revenues have been declining at an average rate of 0.6% per year. Avanos Medical's return on equity is 0.6%, and it has net margins of 1%.
Informazioni chiave
39.3%
Tasso di crescita degli utili
39.3%
Tasso di crescita dell'EPS
Medical Equipment Crescita del settore | 8.9% |
Tasso di crescita dei ricavi | -0.6% |
Rendimento del capitale proprio | 0.6% |
Margine netto | 1.0% |
Ultimo aggiornamento sui guadagni | 30 Jun 2024 |
Aggiornamenti sulle prestazioni recenti
Recent updates
There May Be Some Bright Spots In Avanos Medical's (NYSE:AVNS) Earnings
Aug 07Lacklustre Performance Is Driving Avanos Medical, Inc.'s (NYSE:AVNS) Low P/S
Apr 17Is Avanos Medical (NYSE:AVNS) A Risky Investment?
Jan 05Some Avanos Medical, Inc. (NYSE:AVNS) Analysts Just Made A Major Cut To Next Year's Estimates
Aug 14When Should You Buy Avanos Medical, Inc. (NYSE:AVNS)?
Aug 13Avanos Medical: Leaning Up, Attractive Returns On Incremental Capital, Reiterate Buy
Jul 16We Think Avanos Medical (NYSE:AVNS) Can Manage Its Debt With Ease
Jun 05Avanos Medical, Inc. (NYSE:AVNS) Stocks Pounded By 26% But Not Lagging Market On Growth Or Pricing
May 18Avanos Medical (NYSE:AVNS) Is Looking To Continue Growing Its Returns On Capital
May 07Is Avanos Medical (NYSE:AVNS) Using Too Much Debt?
Mar 02Avanos Medical Q4 2022 Earnings Preview
Feb 20Avanos Medical, Inc. (NYSE:AVNS) Shares Could Be 30% Below Their Intrinsic Value Estimate
Feb 10Why Avanos Medical, Inc. (NYSE:AVNS) Could Be Worth Watching
Jan 13Avanos Medical reports Q3 mixed earnings; reaffirms FY22 guidance
Nov 02Avanos: Recent Entry To Hyaluronic Acid Market Sparks Interesting Debate
Sep 12Avanos Medical Q2 2022 Earnings Preview
Aug 08When Should You Buy Avanos Medical, Inc. (NYSE:AVNS)?
May 28Is Avanos Medical (NYSE:AVNS) Using Too Much Debt?
May 03Is There An Opportunity With Avanos Medical, Inc.'s (NYSE:AVNS) 41% Undervaluation?
Feb 10Should You Think About Buying Avanos Medical, Inc. (NYSE:AVNS) Now?
Dec 21An Intrinsic Calculation For Avanos Medical, Inc. (NYSE:AVNS) Suggests It's 33% Undervalued
Nov 04Avanos Medical (NYSE:AVNS) Takes On Some Risk With Its Use Of Debt
Sep 10The Strong Earnings Posted By Avanos Medical (NYSE:AVNS) Are A Good Indication Of The Strength Of The Business
Aug 10Is There Now An Opportunity In Avanos Medical, Inc. (NYSE:AVNS)?
Jun 30We Think Avanos Medical (NYSE:AVNS) Is Taking Some Risk With Its Debt
Jun 09Ripartizione dei ricavi e delle spese
Come Avanos Medical guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.
Storia dei guadagni e delle entrate
Data | Ricavi | Guadagni | Spese G+A | Spese di R&S |
---|---|---|---|---|
30 Jun 24 | 682 | 7 | 292 | 12 |
31 Mar 24 | 680 | -2 | 309 | 12 |
31 Dec 23 | 673 | -10 | 318 | 13 |
30 Sep 23 | 682 | -11 | 345 | 13 |
30 Jun 23 | 683 | 9 | 346 | 14 |
31 Mar 23 | 684 | 18 | 336 | 15 |
31 Dec 22 | 684 | 22 | 334 | 15 |
30 Sep 22 | 696 | 23 | 332 | 15 |
30 Jun 22 | 708 | -23 | 332 | 16 |
31 Mar 22 | 723 | 10 | 326 | 17 |
31 Dec 21 | 587 | -31 | 257 | 31 |
30 Sep 21 | 736 | -52 | 327 | 10 |
30 Jun 21 | 738 | 2 | 334 | 10 |
31 Mar 21 | 715 | -38 | 334 | 9 |
31 Dec 20 | 715 | -29 | 327 | 35 |
30 Sep 20 | 720 | 14 | 354 | 16 |
30 Jun 20 | 705 | -17 | 366 | 18 |
31 Mar 20 | 714 | -22 | 384 | 19 |
31 Dec 19 | 698 | -46 | 373 | 38 |
30 Sep 19 | 678 | -42 | 389 | 40 |
30 Jun 19 | 671 | -27 | 376 | 41 |
31 Mar 19 | 660 | -17 | 354 | 42 |
31 Dec 18 | 652 | -8 | 327 | 42 |
30 Sep 18 | 649 | -1 | 313 | 43 |
30 Jun 18 | 634 | -16 | 310 | 42 |
31 Mar 18 | 622 | -28 | 318 | 41 |
31 Dec 17 | 612 | -32 | 322 | 38 |
30 Sep 17 | -171 | -150 | 290 | 35 |
30 Jun 17 | 76 | -130 | 311 | 37 |
31 Mar 17 | 327 | -112 | 338 | 37 |
31 Dec 16 | 566 | -83 | 346 | 38 |
30 Sep 16 | 1,584 | 44 | 421 | 17 |
30 Jun 16 | 1,576 | -435 | 418 | 16 |
31 Mar 16 | 1,565 | -434 | 416 | 13 |
31 Dec 15 | 509 | -101 | 350 | 28 |
30 Sep 15 | 1,612 | -443 | 444 | 13 |
30 Jun 15 | 1,631 | 20 | 458 | 11 |
31 Mar 15 | 1,656 | 7 | 460 | 14 |
31 Dec 14 | 1,672 | 27 | 442 | 17 |
30 Sep 14 | 1,664 | 69 | 383 | 40 |
30 Jun 14 | 1,675 | 125 | 354 | 40 |
31 Mar 14 | 1,677 | 168 | 337 | 39 |
31 Dec 13 | 1,678 | 155 | 368 | 21 |
Guadagni di qualità: AVNS has a large one-off loss of $50.7M impacting its last 12 months of financial results to 30th June, 2024.
Margine di profitto in crescita: AVNS's current net profit margins (1%) are lower than last year (1.3%).
Flusso di cassa libero e analisi degli utili
Analisi della crescita degli utili nel passato
Andamento degli utili: AVNS has become profitable over the past 5 years, growing earnings by 39.3% per year.
Accelerare la crescita: AVNS's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Guadagni vs Settore: AVNS had negative earnings growth (-18.6%) over the past year, making it difficult to compare to the Medical Equipment industry average (5.5%).
Rendimento del capitale proprio
ROE elevato: AVNS's Return on Equity (0.6%) is considered low.